Clinical trial
A Phase 1/2 Study of Cytokine-Induced Memory-Like NK Cells in Patients With AML or MDS
NCT01898793 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1/2 Study of Cytokine-Induced Memory-Like NK Cells in Patients With AML or MDS
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- August 11, 2014
- Completion date
- April 4, 2022
- Enrollment
- 89 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.